Denmark· DK-28104132407

Masivet

A ql01ex06 product containing masitinibmesilat, registered in Denmark by AB Science S.A..

ATC QL01EX06

Checked against Danish Medicines Agency (Denmark) on

Informational only — not a medical device.

SOURCE REGISTER · DKDanish Medicines Agency (Denmark)normalisedMasivetATCQL01EX06REGISTER NO.DK-28104132407PACKS LISTED1CHECKEDSeptember 30, 2026

The record

At a glance

Danish Medicines Agency (Denmark)
Active substance
Masitinibmesilat
Manufacturer
AB Science S.A.
Country
Denmark (DK)
ATC code
QL01EX06
ATC class
QL01EX06
Reimbursed
Not published by this register
Source register
Danish Medicines Agency (Denmark)
Last checked
September 30, 2026

Packs & prices · 1

  • dk_varenummer
    28104132407

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under QL01EX06

Ql01ex06, as other registers publish it.

All masitinibmesilat products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f5192661-73e6-4117-82f9-9d92fa0e7a99
GET /v1/drugs/f5192661-73e6-4117-82f9-9d92fa0e7a99?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "filmovertrukne tabletter",
  "source": "dkma",
  "strength": "50 mg",
  "auth_role": "MOD",
  "dk_drugid": "28104132407",
  "substance": "Masitinibmesilat",
  "auth_procedure": "Central",
  "in_medicinpriser": false,
  "registration_date_serial": "39769"
}

See everything about masitinibmesilat.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.